• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM
Click for more information
5.26% 1.8¢

CHIMERIC THERAPEUTICS LIMITED

Market Cap $16.64M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM
Chimeric: Media Thread
10 11 12
10:47 711 289K
10:47 Last post  Steini Comments Created with Sketch.  711  Views Created with Sketch.  289K 
CHM
CHM's Future 		02/07/24 22 8.8K
02/07/24 Last post  pinch2020 Comments Created with Sketch.  22  Views Created with Sketch.  8.8K 
CHM
Ann: Notice under section 708A 		28/06/24 0 247
28/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  247 
CHM
Ann: Application for quotation of securities - CHM 		28/06/24 0 224
28/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  224 
CHM
Ann: Notice of Extraordinary General Meeting/Proxy Form
3 4 5
27/06/24 284 72K
27/06/24 Last post  Steini Comments Created with Sketch.  284  Views Created with Sketch.  72K 
CHM
Ann: Notification of cessation of securities - CHM 		26/06/24 0 324
26/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  324 
CHM
Charting Only
6 7 8
25/06/24 451 158K
25/06/24 Last post  dalts66 Comments Created with Sketch.  451  Views Created with Sketch.  158K 
CHM
Webinar 17/06/24 		19/06/24 25 6.6K
19/06/24 Last post  Cuprum29 Comments Created with Sketch.  25  Views Created with Sketch.  6.6K 

See All Discussions arrow Created with Sketch.

Timeline

Notice under section 708A
28 Jun 16:38
 
Application for quotation of securities - CHM
28 Jun 16:34
 
Notification of cessation of securities - CHM
26 Jun 16:57
 
Results of Meeting
11 Jun 11:00
 
Presentation to Extraordinary General Meeting
11 Jun 08:46
 
Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA
05 Jun 09:11
 
View More arrow Created with Sketch.

Featured News

ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
(20min delay)
Last
1.8¢ 		Change
-0.001(5.26%) 		Mkt cap ! $16.64M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $4.562K 242.3K

Buyers (Bids)

No. Vol. Price($)
9 1631024 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 8684 1
View Market Depth
Last trade - 10.50am 03/07/2024 (20 minute delay) ?
Last
1.8¢ 		  Change
-0.001 ( 0.55 %)
Open High Low Volume
1.9¢ 1.9¢ 1.8¢ 889202
Last updated 11.13am 03/07/2024 ?
CHM (ASX) Chart

Top Stories

Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76%

Sovereign Metals Ltd has seen a boost to its Kasiya rutile graphite project in Malawi, as Rio Tinto increases its interest in the company.
Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.
Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4 Ark Mines has published an Exploration Target for its Sandy Mitchell REE project of up to 1.5B tonnes @ up to 1490ppm monazite equivalent
Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project  The company has locked in a drilling contractor to fire up a Reverse Circulation (RC) drill rig at Maverick starting on 8th of July US time. 
Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25 Uranium was one bright spot at the start of 2024, standing out against otherwise glum markets that defined 2023.

Featured News

AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.